Home > PJ (current issue)> Articles

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7300 p644
22 May 2004

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Articles

Students are better than they think at conducting home medication reviews

Research published in the June issue of the International Journal of Pharmacy Practice is highlighted by Joanna Lumb, managing editor, IJPP


Experience in domiciliary medication review (DMR) should be included in the education of pharmacy students and pre-registration trainees, say Australian researchers after reporting positive findings from a study assessing the ability of final (fourth) year pharmacy students to carry out supervised DMR.

Thirty-six students undertook medication reviews of 189 patients, most of whom were aged over 60 years. The students were able to identify medication-related problems, many of which were subsequently endorsed by pharmacists and GPs. Using the students’ reports, the GPs indicated that 10 per cent of patients required a change in therapy. In four patients (2 per cent) the medication problems were considered clinically significant by the GP. Student-conducted DMR was acceptable to patients — who commented on the students’ professional approach — and to the GPs and pharmacists participating in the project. Surprisingly, the students’ view of their role, and of the value of DMR as a component of their training, was weaker than that of the supervising pharmacists and GPs, but anecdotal comments suggested that confidence would have been improved if they had had more training.

The researchers conclude: “It is evident that our students fulfilled a useful role in the DMR process while applying their knowledge in a challenging practice environment and gaining experience in an important aspect of contemporary pharmacy practice.”

Sale of non-prescription medicines

In another primary care study, reported from Scotland, pharmacists and their staff were found to face a range of barriers to the evidence-based supply of non-prescription medicines. The study involved observation of medicine sales in nine pharmacies and staff interviews. Personal experience and feedback from customers were cited as evidence on which treatment recommendations were made, but no obvious evidence — such as guidelines, protocols or other information on best practice — was used in the majority of consultations.

The researchers acknowledge that there has been little rigorous evaluation of evidence associated with non-prescription medicines but say that pharmacists and their staff need to be aware of the importance of using evidence, where possible, to inform the supply of non-prescription medicines. “Interventions need to be identified and investigated as methods of promoting evidence-based practice,” they say.

Other barriers to the appropriate supply of non-prescription medicines included questioning and communication skills (which were highly variable), limited ongoing training of medicines counter assistants and no formal criteria on when to refer to the pharmacist. The authors say that as medicines counter assistants are involved in over 70 per cent of non-prescription medicine consultations there is an urgent need to address their continuing education requirements.

Questionnaire surveys

Quantitative data on headache and its treatment were collected from 2,662 adults in a cross-sectional survey of a population sample in five general practices in North Staffordshire. Seventy per cent of respondents reported having headache in the past three months and 85 per cent of them had taken medicines for it. Medicines use was more likely to be reported by women and by those aged 36 to 50.

The majority had taken medicines bought from a pharmacy, with paracetamol being by far the most widely used analgesic. Thirty per cent of medicines users reported taking at least one combination therapy, such as products containing codeine or caffeine, or both. Few respondents used migraine-specific treatments, such as triptans, presumably, say the researchers, because they had not consulted their GP.

The researchers say that their data indicate that most people are using medicines appropriately, with two-thirds of users treating their headaches with simple analgesics. However, for the users who reported that treatment was ineffective (2 per cent) or only partially effective (51 per cent), advice about other potential therapies or medical referral may be appropriate. Also, although a minority used combination therapy, the high prevalence of headache means that this equates to substantial numbers in the population as a whole and the researchers comment that health professionals should discourage analgesic overuse.

A UK hospital research paper reports a questionnaire survey to investigate the involvement of pharmacists in the monitoring of antibiotic prescribing. It involved investigation of the availability of antibiotic prescribing control documents and pharmacists’ role in implementation of antibiotic policy.

Over 90 per cent of the 253 responding hospitals had at least one antibiotic prescribing control document: 168 hospitals had an antibiotic formulary, 107 had an antibiotic policy and 216 had antibiotic guidelines.

Pharmacists routinely reviewed adherence to prescribing recommendations in 83 per cent of hospitals. In 77 per cent of these hospitals, review was undertaken on all wards while in others it was only undertaken on selected wards (generally the intensive care unit). Antibiotic prescribing review was proactive and generally covered drug, dosage, regimen length, drug interactions and patient factors.

Most pharmacists discussed problems directly with the prescriber but their intervention was often not recorded in the notes or on the prescription. The researchers say that in around one-third of hospitals, pharmacists communicated interventions verbally, annotated prescriptions and attended ward rounds. They describe this combination of antibiotic prescribing control mechanisms as “best practice” and recommend its implementation in all hospitals.

IJPP online

The IJPP is available online via Ingenta.com. The full text is only available to online or print/online subscribers. Print-only subscribers and non-subscribers can purchase papers online on a “pay per view” basis. Abstracts are available free of charge to all users. Further information is available here

Back to Top


©The Pharmaceutical Journal